Minimally important difference estimates for the UCLA SCTC GIT 2.0 scales. Negative score denotes improvement.
| UCLA SCTC GIT 2.0 | MID Estimates |
|---|---|
| Reflux | |
| Somewhat better | −0.26 |
| Somewhat worse | 0.19 |
| Distension/bloating | |
| Somewhat better | −0.14 |
| Somewhat worse | 0.12 |
| Diarrhea | |
| Somewhat better | −0.19 |
| Somewhat worse | 0.07 |
| Constipation | |
| Somewhat better | −0.17 |
| Somewhat worse | 0.13 |
| Fecal soilage | |
| Somewhat better | −0.19 |
| Somewhat worse | 0.06 |
| Emotional well-being | |
| Somewhat better | −0.36 |
| Somewhat worse | 0.16 |
| Social functioning | |
| Somewhat better | −0.07 |
| Somewhat worse | 0.21 |
| Total GIT score | |
| Somewhat better | −0.20 |
| Somewhat worse | 0.12 |
UCLA SCTC GIT: University of California at Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract; MID: minimally important difference.